melanomaBRAF-mutant advanced melanoma
…ions.3 4 In previous treatment eras (2006 to 2016), BRAF-mutant melanoma was characterised as aggressive, particularly in advanced stage…
22articles mentioning diseases
38disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: advanced melanoma ×
advanced melanoma
This disease is selected. Its supporting articles are shown below.
Articles mentioning advanced melanoma
22 articles · page 1 of 2renal cell carcinomacervical cancerPneumocystis jirovecii pneumoniaosteosarcomanon-small cell lung canceruveal melanoma
…apy has been tested in other solid tumour malignancies, such as renal cell carcinoma (29% ORR in 7 patients),49 non-small cell lung cancer (23% ORR …
advanced melanomamelanomalifileucelMassachusetts General HospitalDana-Farber/Harvard Cancer CenterMass General Cancer Center Tumor Cartography Centeradoptive T cell therapyDr. Miriam and Sheldon G. Adelson Medical Research Foundation
…or-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted …
advanced melanomanivolumab
…tional endpoints. TFS was previously evaluated in patients with advanced melanoma treated with nivolumab plus ipilimumab. This analysis compared …
advanced melanomaMIMicICIFecal microbiota transplantation
…survival data based on over 3 years of follow-up. Patients with advanced melanoma and treatment-naïve for advanced disease received a single FMT …
advanced melanomabromocriptinemetoclopramideMCPFDA-approvedBRCFood and Drug AdministrationCollaborative Cross mice
…s as cotherapeutics to overcome ICI resistance in patients with advanced melanoma.…
advanced melanomamelanomaMelanoma-intrinsicnivolumabUniversity of California IrvineipilimumabChao Family Comprehensive Cancer CenterPD-1 blockadeNSF-GRFP fellowshipPD-1 immunotherapy+3 more
…tors. Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2025;392(1):11–22.Geels SN, Moshensky A, Sousa R…
advanced melanomastage III/IV unresectable melanomaPembrolizumabNCT05309421
…aluated in combination with Pembrolizumab in a phase 2 trial in advanced melanoma ( NCT05309421), with 80% of the vaccine targets eliciting T-cel…
advanced melanomamelanomaCX-801pembrolizumab
…otherapy and in combination with pembrolizumab in patients with advanced melanoma ( NCT06462794). Key objectives include safety, PD, PK, and prel…
87.8%
melanomaadvanced melanomaadoptive cell therapyprogrammed death-1 inhibitor
…ously described.Patients and methods Patients with unresectable melanoma who received ICI therapy both before and after TIL treatment we…
advanced melanomaUS Food and Drug AdministrationHealth CanadaHD-IL-2first-line immune checkpoint inhibitorsAutologous tumor-infiltrating lymphocyte (TIL) therapyinduction chemotherapy regimen
…istration and Health Canada for the management of patients with advanced melanoma refractory to first-line immune checkpoint inhibitors, with reg…
advanced melanomacancerlow molecular weight heparinplatelet inhibitorsoral factor Xa (FXa) inhibitorsanticoagulation
…CI efficacy, one retrospective study found improved outcomes in advanced melanoma patients treated with ICI and FXa inhibitors. Additionally, ano…